Cook Children's Medical Center
Cook Children's Medical Center was paid $21.29M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
FORT WORTH, TX 76104
Next to other Pediatrics Physician providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,340 | $39K | |
| 2019 | 773 | $27K | |
| 2020 | 15,288 | $594K | |
| 2021 | 106,233 | $4.20M | |
| 2022 | 137,665 | $6.99M | |
| 2023 | 124,500 | $6.29M | |
| 2024incomplete | 58,573 | $3.15M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 145,055 | 142,100 | $7.34M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 21% | 89,941 | 87,861 | $4.56M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 14% | 38,252 | 37,552 | $3.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 36,880 | 36,286 | $2.75M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 8.2% | 59,875 | 58,421 | $1.76M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.2% | 14,202 | 13,934 | $1.11M |
| 87634 | <1% | 3,707 | 3,543 | $194K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 9,215 | 9,035 | $165K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,102 | 1,078 | $134K |
| 74018 | <1% | 4,762 | 4,685 | $82K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,735 | 2,407 | $38K |
| 81003 | <1% | 10,685 | 10,428 | $20K |
26 more codes
| 51701 | <1% | 286 | $10K | |
| 73610 | <1% | 362 | $8K | |
| 69210 | <1% | 129 | $5K | |
| 73630 | <1% | 210 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,684 | $4K |
| 84703 | <1% | 630 | $4K | |
| 82947 | <1% | 1,004 | $3K | |
| 73140 | <1% | 136 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 191 | $3K |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 6,512 | $2K |
| 94761 | <1% | 2,536 | $2K | |
| 29105 | <1% | 26 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 130 | $2K |
| A4353 | Intermittent urinary catheter, with insertion supplies | <1% | 304 | $2K |
| 69209 | <1% | 109 | $1K | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 6,572 | $1K |
| 73562 | <1% | 26 | $648.80 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $528.66 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $417.09 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,535 | $224.58 |
| 73090 | <1% | 13 | $200.10 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 455 | $30.23 |
| 99000 | <1% | 35 | $22.36 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 12 | $0.00 |
| Q0181 | Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 28 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Cook Children's Medical Center | Fort Worth, TX | $286.65M |
| Cook Children's Medical Center | Mansfield, TX | $4.64M |
| Cook Children's Medical Center | Fort Worth, TX | $4.59M |
| Cook Children's Medical Center | Fort Worth, TX | $3.84M |
| Cook Children's Medical Center | Hurst, TX | $3.41M |
| Cook Children's Medical Center | Southlake, TX | $2.15M |
| Cook Children's Medical Center | Aledo, TX | $1.97M |
| Cook Children's Medical Center | Fort Worth, TX | $1.97M |
| Cook Childrens Medical Center - Prosper | Prosper, TX | $1.16M |
| Cook Children's Medical Center | Prosper, TX | $934K |
| Cook Children's Medical Center | Fort Worth, TX | $900K |
| Child Study Center | Fort Worth, TX | $117K |
| Cook Children's Medical Center | Fort Worth, TX | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.